IRIS
SAMBATARO, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.364
AS - Asia 1.059
EU - Europa 580
SA - Sud America 224
Continente sconosciuto - Info sul continente non disponibili 186
AF - Africa 20
OC - Oceania 1
Totale 4.434
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.296
SG - Singapore 352
IT - Italia 273
HK - Hong Kong 197
CN - Cina 187
BR - Brasile 165
BD - Bangladesh 122
VN - Vietnam 111
SE - Svezia 66
DE - Germania 64
FR - Francia 55
CA - Canada 36
AR - Argentina 27
IE - Irlanda 24
GB - Regno Unito 21
IN - India 19
AT - Austria 18
ID - Indonesia 17
NL - Olanda 16
EC - Ecuador 13
MX - Messico 12
TR - Turchia 11
FI - Finlandia 10
IQ - Iraq 8
CR - Costa Rica 7
PL - Polonia 7
ZA - Sudafrica 7
CO - Colombia 6
ES - Italia 6
RU - Federazione Russa 6
CL - Cile 5
JP - Giappone 5
MA - Marocco 5
AZ - Azerbaigian 4
BB - Barbados 3
GT - Guatemala 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
IL - Israele 2
JM - Giamaica 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PK - Pakistan 2
PR - Porto Rico 2
PY - Paraguay 2
SA - Arabia Saudita 2
UA - Ucraina 2
VE - Venezuela 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GR - Grecia 1
HR - Croazia 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MN - Mongolia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 4.249
Salva come PNG Salva come JPEG
Città #
Dallas 1.214
San Jose 199
Hong Kong 196
Singapore 150
Ashburn 112
Council Bluffs 72
Ho Chi Minh City 54
Chicago 46
The Dalles 44
Beijing 40
New York 37
Milan 35
Santa Clara 33
Phoenix 32
Dublin 24
Naples 23
Rome 16
São Paulo 16
Catania 14
Hanoi 13
Los Angeles 12
Montreal 12
Buffalo 11
Hillsboro 11
Frankfurt am Main 10
Turin 10
Helsinki 8
Istanbul 8
Munich 8
Orem 8
Palermo 8
Rio de Janeiro 8
Amsterdam 7
Boardman 7
Mexico City 7
Bemidji 6
Boston 6
Chennai 6
Düsseldorf 6
Miami 6
Quito 6
Seattle 6
Biên Hòa 5
Bologna 5
Brasília 5
Guayaquil 5
Manchester 5
Misilmeri 5
Nuremberg 5
Porto Alegre 5
San José 5
Vienna 5
Warsaw 5
Assago 4
Atlanta 4
Baghdad 4
Baku 4
Brooklyn 4
Curitiba 4
Dhaka 4
Genoa 4
Haiphong 4
Limburg an der Lahn 4
North Hollywood 4
San Francisco 4
Stony Brook 4
Triggiano 4
Abbeville 3
Bari 3
Buenos Aires 3
Cagliari 3
Campinas 3
Casoria 3
Durban 3
Ealing 3
Guarulhos 3
Guatemala City 3
Houston 3
Indianapolis 3
Johannesburg 3
Joinville 3
London 3
Longone al Segrino 3
Memphis 3
Messina 3
Mumbai 3
Resistencia 3
Ribeirão Preto 3
Tashkent 3
Toronto 3
Varallo Pombia 3
Verona 3
Abbotsford 2
Alessandria 2
Ann Arbor 2
Arlington 2
Avellino 2
Bandung 2
Belo Horizonte 2
Bogotá 2
Totale 2.749
Salva come PNG Salva come JPEG
Nome #
Opsoclonus-myoclonus Syndrome in a Female Breast Cancer Patient: A Case Report and Literature Review 287
Neurocrine tumors of the lung [I TUMORI NEUROENDOCRINI DEL POLMONE] 260
Management of ocular toxicity in patients with gynecologic cancer receiving novel antibody–drug conjugates: a narrative review 243
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: A phase II study 189
A Survey on the Prescribing Orientation Towards Complementary Therapies Among Oncologists in Italy: Symptoms and Unmet Patient Needs 94
A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF Mutation 92
Breast-Conserving Surgery in BRCA Mutation Carriers: A Paradigm Shift Toward Individualized, Multidisciplinary Care 90
Brain Metastasis in Endometrial Cancer: A Systematic Review 89
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial 88
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial 87
Livelli sierici del recettore solubile dell’interleuchina 2 in pazienti con carcinoma del polmone in stadio III o IV in trattamento antiblastico o radiante Livelli sierici del recettore solubile dell’interleuchina 2 in pazienti con carcinoma del polmone in stadio III o IV in trattamento antiblastico o radiante 85
Combined Neuroendocrine Carcinoma and Hepatocellular Carcinoma of the Liver: Systematic Literature Review Suggests Implementing Biological Characterization to Optimize Therapeutic Strategy 84
Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer 81
A Practical Narrative Review on the Role of Magnesium in Cancer Therapy 73
Risk-reducing mastectomy in healthy women with BRCA mutation: a narrative review 72
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study 71
Nonpegylated liposome-encapsulated doxorubicin (NPLED) and cyclophosphamide in the treatment of platinum-resistant ovarian cancer: Final results of a phase II study 70
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II study 67
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 65
Unusual presentation of luminal breast carcinoma metastatic to the brain and coma: a case report of dramatic response to abemaciclib and literature review 65
Prognostic Factors for Adrenocortical Carcinoma Outcomes 64
Relationship of Inflammatory Parameters and Nutritional Status in Cancer Patients 63
A Survey on Knowledge and Attitudes Towards Vaccination Against Herpes Zoster Virus Among Medical Oncologists for Patients with Solid Tumors 63
[Second-line chemotherapy and new drugs for ovarian carcinoma] 62
Chemotherapy extravasation: diagnosis, prevention and management 61
Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion 61
LONG-TERM CANCER SURVIVORS: CONCERNS AND UPDATES 59
A combined hepatocellular/cholangiocellular carcinoma with sarcomatoid features 57
IL-6-174 G>C and MMP-9-1562 C>T polymorphisms are associated with increased risk of deep vein thrombosis in cancer patients 56
Immune checkpoint inhibitor therapy‑related pneumonitis: How, when and why to diagnose and manage (Review) 55
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach 52
Exploratory Analysis of Dunning–Kruger Effect Among Oncologists Managing Prostatic Adenocarcinoma Candidates for Radionuclide Therapy 51
Characteristics and management of hepatocellular carcinoma (HCC) in Sicily: first results of the HCC Sicily Multidisciplinary Network 51
Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey 50
Phase II Study of the Effectiveness of the Germinated Wheat-derived Rigenase Plus Polyhexanide in the Prophylaxis for Hypofractionated Radiation-induced Acute Skin Toxicity in Breast Cancer 49
Effectiveness of low molecular weight heparin (LMWH) in cancer-related disseminated intravascular coagulation (DIC). A case report 47
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial 45
Bronchial carcinoid associated with Cushing's syndrome 45
The immune system response during development and progression of carcinogen-induced rat mammary tumors: prevention of tumor growth and restoration of immune system responsiveness by thymopentin 43
Bronchial carcinoid associated to Cushing syndrome|IL CARCINOIDE BRONCHIALE ASSOCIATO A SINDROME DI CUSHING 42
Assessing awareness and knowledge of Human Papilloma virus infection in high school studente 33
Il sistema immunitario durante la progressione tumorale: approccio sperimentale e clinico 32
The pathology of medullary carcinoma of the thyroid: Review of the literature and personal experience on 62 cases 32
Activity and safety of CPBev regimen (cisplatinum, pemetrexed, and bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: Final results of a phase II study. 30
Activity and safety of CPBev regimen (Cis-platinum, Pemetrexed and Bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: final results of a phase II study. 29
Melanoma Sliding Doors 2022 Management and targeted treatment for melanoma BRAF+ patients 27
ATHENA (GOG-3020/ENGOT-ov45): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Study of the Poly (ADP-Ribose) Polymerase (PARP) Inhibitor Rucaparib + the PD-1 Inhibitor Nivolumab Following Frontline Platinum-Based Chemotherapy in Ovarian Cancer 27
Il trattamento del carcinoma gastrico localmente avanzato e metastatico in regime di day hospital: possibilità di applicazione dell’infusione continua (ECF) 26
Follow up of colorectal cancer 26
Il deficit cognitivo nei pazienti oncologici in trattamento antiblastico. 26
Utilità di un follow up accurato nel trattamento delle metastasi polmonari ed epatiche da carcinoma colo-rettale: descrizione di due casi clinici. 24
Implementation of a clinical governance model (UFA-ONCO-HEMA model) for anticancer drugs delivering and its adoption by a Regional Health Department 24
Adjuvant treatment of colo-rectal cancer with combined chemotherapy and radiation therapy 23
Study on the perception of memory and concentration deficit of patients undergoing antiblastic therapy. 23
Oxaliplatin (L-OHP), folinic and fluorouracil (5FU) for advanced breast cancer (BC) patients (pts) refractary to anthracyclines (ant) and taxanes (tax). 23
Escalating Doses of gemcitabine in combination with cisplatin in advanced urothelial carcinoma: a dose finding study. 23
Gemcitabine (G) as a six-hour infusion in patients (pts) with metastatic, largely treated, solid tumours. 23
Pegylated liposomial doxorubicin with escalating dose vinorelbina in metastatic breast carcinoma: a dose finding study. 22
PRELIMINARY DATA OF THE ASSOCIATION OF CIS-PLATINUM, PEMETREXED AND BEVACIZUMAB (CPBEV) AS FIRST-LINE THERAPY FOR LOCALLY ADVANCED OR METASTATIC ADENOCARCINOMA OF THE LUNG 21
Retrospective study about treatment protocol of an advanced colorectal carcinoma by 5fluouracil double modulation by leucovorin and interferon. 21
THE ONCOLOGICAL SITUATION IN SICILY: PUBLIC AND PRIVARE STRUCTURES 21
Second- and third-line chemotherapy in advanced gastric cancer: a real-life clinical picture. 21
Effetto dell’interleuchina 2 sulla mucosite indotta da trattamento citostatico con 5 fluorouracile ad alte dosi in infusione continua e acido folinico in pazienti con adenocarcinoma del colon retto in stadio avanzato. 20
A data collection representative of an outcome analysis in advanced Non Small Cell Lung Cancer (NSCLC) expressing EGFR mutations after failure of first line therapy with Tyrosine Kinase Inhibitors (TKIs) with careful on post progression survival 20
Nutritional Status, Inflammatory Parameters and Cancer 19
Preliminary study on financial toxicity perception among cancer patients: The financial toxicity questionnaire 16 19
Trombosi e Cancro 19
Tossicità dell’associazione RT-CT nel carcinoma del retto: valutazione della fattibilità in rapporto al regime citostatico adottato 19
Melanoma Setting Next Horizon 2023. Mnagement and targeted treatment for melanoma BRAF+ Patients. 19
5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) plus Bevacizumab in patients with metastatic colo-rectal cancer (MCRC): a multicentric phase II trial 19
Phase II study of irinotecan and fluorouracil/leucovorin (FOLFIRI) in patients with primary advanced gastric cancer. Preliminary results 18
Doppia modulazione del 5 FU con Leucovorin ed Interferon * nel carcinoma colorettale in stadio avanzato. Risultati di uno studio clinico. 18
Drug-drug interaction between antineoplastic drug based protocols and general medications: a novel approach in the clinical practice 18
Toxicity From Monoimmunotherapy In Patients Aged =80 Years: Our Experience 18
Importanza di una adeguata terapia nutrizionale di supporto nel paziente neoplastico in fase avanzata: l’esperienza di un day hospital oncologico. 17
The clinical governance model (UFA-ONCO-EMA model) for anticancer drugs delivering of the ARNAS Garibaldi: third year experience 16
Tumor markers in the diagnosis, prognosis, and follow-up of colorectal cancer: CEA, CA 19-9 and TPA 16
MITO-11 - A randomized multicenter phase II trial testing the addition of pazopanib to weekly paclitaxel in platinum resistant or refractory advanced ovarian cancer (AOC) 15
Escalating Doses of Paclitaxel in combination with Epirubicin and Cisplatin in Advanced Ovarian Epithelial Carcinoma: A Dose Finding Study. 15
Beyond BRCA: preliminary results of a study for the implementation of hereditary cancer diagnoses. 15
Chemotherapy for transitional cell carcinoma (TCC) patients (pts) unsuitable to cisplatinum: a phase II study of gemcitabine (G) and vinorelbine (V) combination. 15
Terapia adiuvante e qualità di vita: tossicità del trattamento con folati e 5-FU a scopo precauzionale e sue implicazioni cliniche 15
Neoadjuvant chemotherapy followed by surgery in patients with squamous cell cervical carcinoma 15
Observational Study on the Effectiveness of L-Arginine Plus Vitamin C in the Management of Cancer-related Fatigue 14
Pertuzumab, Trastuzumab, Docetaxel: a single istitution clinical exeperience for Her 2 positive metastatic breast cancer (mBC) 14
Neuroimmunomodulation in Neoplasia: Role of Cytokines and Thimic Hormones 14
The Astrocyte as Target and Source of Mediators of Immune and Neuroendocrine Systems The Astrocyte as Target and Source of Mediators of Immune and Neuroendocrine Systems 14
From Feasibility to Individualization: Surgery for Breast Cancer Liver and Lung Metastases 13
Examining perceptions of financial toxicity among cancer patients: The Financial Toxicity 16 Questionnaire. 13
Metronomic shedule of Capecitabine in poor performance status Patients (PTS) with pretreated solid tumors 13
Tromboembolismo in oncologia medica 12
Descrizione e valutazione di alcuni casi di metastasi epatiche da carcinomi del grosso intestino trattate con terapia citostatica e successiva resezione 12
Valutazione di CEA, TPA E CA 15.3 nel follow-up del carcinoma della mammella e nel monitoraggio della risposta alla terapia nella fase avanzata. 11
Determinazione della Triiodiotironina con tecniche immunochimiche non radioisotopiche Determination of Triiodiothyronine by non radioisotopic techniques 11
Adjuvant endocrine therapy in estrogen-low breast cancer in the era of CDKI: are we at another uncertain crossroads? 10
Preclinical Rationale, Clinical Efficacy, and Safety of the Selective AKT Kinase Inhibitor Capivasertib in Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Carcinoma: A Practical Narrative Review 9
Scientific Clinical Trial Publication Productivity in Medical Oncology: A Comparative Analysis and Data Review of Northern and Southern Italy 9
Magnesium and Cancer Immunotherapy: A Narrative Practical Review 8
Scientific Meetings in Medical Oncology: Are We Facing a Time- and Resource-Consuming Plethora? 7
Totale 4.434
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.446
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20245 0 0 0 0 0 0 0 0 0 0 0 5
2024/2025610 12 5 9 2 18 96 68 44 69 121 84 82
2025/20263.269 103 282 1.122 256 230 221 124 253 195 170 200 113
2026/2027550 56 112 156 226 0 0 0 0 0 0 0 0
Totale 4.434